BackFinch Therapeutics Group Overview

Finch Therapeutics Group Receivables

Track Finch Therapeutics Group's receivables ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00

Peer average

Loading

Finch Therapeutics Group Receivables History

Loading

Finch Therapeutics Group vs. peers: Receivables Comparison

Loading

Finch Therapeutics Group Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Finch Therapeutics Group (FNCH) FAQ

Finch Therapeutics Group (FNCH) currently reports a receivables of $0 as of June 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Finch Therapeutics Group's receivables history and peer comparisons.

Finch Therapeutics Group's receivables changed from $0 to $0 (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Finch Therapeutics Group reported $0 in receivables as of June 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Finch Therapeutics Group, and consider following FNCH for alerts when major investors trade the stock.

Finch Therapeutics Group is classified in the Healthcare sector. On receivables, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FNCH with unrelated industries.